Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1444 studies found for:    Open Studies | "Lymphatic Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.
Condition: Lymphatic Diseases
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib;   Drug: CHOP
2 Recruiting A Phase II Study With Bendamustine Plus Brentuximab Vedotin in Hodgkin's Lymphoma and CD30+ Peripheral T-cell Lymphoma in First Salvage Setting: the BBV Regimen
Condition: Lymphatic Diseases
Interventions: Drug: Brentuximab Vedotin;   Drug: Bendamustine
3 Recruiting Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients
Condition: Lymphatic Diseases
Intervention: Drug: Brentuximab Vedotin
4 Recruiting International Lymphatic Disease and Lymphedema Registry
Condition: Lymphedema
Intervention:
5 Recruiting Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Conditions: Lymphatic Diseases;   Hematopoietic Malignancy
Intervention: Biological: Umbilical Cord Blood (UCB)
6 Recruiting Sildenafil for the Treatment of Lymphatic Malformations
Conditions: Lymphatic Malformations;   Lymphatic Diseases
Interventions: Drug: Sildenafil 20 mg tablets;   Other: Placebo tablets (resembling Revatio)
7 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
Intervention:
8 Not yet recruiting Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development
Condition: Lymphedema
Intervention: Drug: Indocyanine Green (ICG)
9 Not yet recruiting Lymphaticovenous Anastomosis for Breast Cancer-related Lymphedema
Condition: Lymphedema
Intervention: Procedure: Lymphaticovenous anastomosis (LVA)
10 Recruiting Prospective Evaluation of the Biobridge Scaffold as an Adjunct to Lymph Node Transfer for Upper Extremity Lymphedema
Conditions: Lymphedema;   Edema
Intervention: Device: Biobridge and lymph node transfer
11 Recruiting Multi-Parametric Assessment of Breast Lymphedema
Conditions: Breast Cancer;   Breast Lymphedema
Intervention: Other: non-invasive image & bioimpedance based techniques
12 Recruiting Ubenimex in Adult Patients With Secondary Lymphedema of The Lower Limb (ULTRA)
Condition: Lymphedema
Interventions: Drug: ubenimex;   Other: placebo
13 Recruiting NIR Fluorescence Imaging of Lymphatic Transport Using ICG
Condition: Lymphedema
Interventions: Drug: Indocyanine Green;   Device: MultiSpectral Imaging System
14 Recruiting Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic
Condition: Chronic Histiocytosis
Intervention:
15 Recruiting Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced PCD
Condition: Lymphedema
Intervention: Device: Advanced Pneumatic Compression Device
16 Recruiting Lymphedema Progression Screening Using MRI
Conditions: Lymphedema;   Breast Cancer
Intervention: Procedure: Manual lymphatic drainage therapy
17 Not yet recruiting Propranolol Dose Escalation in Lymphedema in Patients
Condition: Primary Lymphedema
Intervention: Drug: Propranolol
18 Recruiting Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)
Condition: Lymphedema
Intervention: Other: ITP
19 Recruiting Comfort Subcutaneous Drainage: a Descriptive Study Among Palliative Phase Cancer Patients
Condition: Lymphedema
Intervention: Procedure: subcutaneous drainage
20 Not yet recruiting Manual Lymphatic Drainage in the Superior Member in Women in Post-surgery for Breast Cancer
Condition: Lymphedema
Interventions: Other: Without upper limb elevation;   Other: Upper limb elevation to 30º

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.